GEF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GEF is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive capital-allocation and cost-saving positives, but the latest quarter showed sharp revenue and earnings deterioration, and the technical trend is still weak. Since there is no AI Stock Picker or SwingMax buy signal today, the best call is to hold off rather than buy immediately.
GEF is trading pre-market at 65.24, slightly below the pivot level of 66.723 and below resistance at 69.978. MACD histogram is -0.304 and still expanding negatively, which supports bearish momentum. RSI_6 at 25.518 is deeply weak but not yet producing a clean reversal signal. Moving averages are converging, suggesting the stock may be trying to stabilize, but current price action still looks fragile. The short-term pattern outlook is also soft, with projected near-term returns slightly negative over the next week and month.
Greif delivered $75 million in cost savings in Q2 and is targeting $80 million to $90 million for the full year. Adjusted free cash flow improved 107% year over year to $90 million. The company maintained a low leverage ratio of 1.1x after a $150 million share repurchase program, and debt was reduced to about $1.006 billion. Adjusted EBITDA rose 7.5% despite weaker revenue, showing some operational resilience.
Management also lowered the low end of adjusted EBITDA guidance to $610 million due to Middle East conflict impacts. Price-target action was also cautious, with BofA cutting its target to $71 from $75 and keeping a Neutral rating. There is no recent support from insider buying, hedge fund accumulation, or congress trading activity.
Latest quarter: Q2 2026. Financials were mixed to weak. Revenue declined 22.58% year over year to $1.0728 billion, net income fell 73.36% to $12.6 million, and EPS dropped to 0 from a positive prior-year level. Gross margin slipped slightly to 23.02%. On the positive side, adjusted EBITDA increased 7.5% to $156.8 million and adjusted free cash flow improved strongly, indicating better cash generation even as top-line performance weakened.
Recent analyst trend is cautious. On 2026-04-06, BofA lowered its price target on Greif to $71 from $75 and kept a Neutral rating. That reflects a pros-and-cons Wall Street view that is balanced but not bullish: the pros are lower leverage, cost savings, and better cash flow; the cons are falling revenue, lower earnings, and limited upside conviction from analysts. Overall analyst sentiment is neutral-to-cautious rather than supportive of an aggressive buy.
